Riskpilot← Back to searchSign inGet full accessDr Pia Aldenmalm AB
ABActiveOrg 5567429526Stuvhult GranbackenMedical specialists activities · NACE 8622Est. 20071 employees
Revenue 2024
SEK 841K
-18% vs 2023
EBITDA margin
22.5%
-55% vs 2023
Equity ratio
79.8%
Financial strength
Net profit 2024
SEK 159K
-52% vs 2023
| Revenue | SEK 841K | -18% |
| EBITDA | SEK 189K | -55% |
| Net profit | SEK 159K | -52% |
| Total assets | SEK 4,7M | -17% |
| Equity | SEK 3,7M | -2% |
| Employees | 1 | — |
Legal name
Dr Pia Aldenmalm AB
Org number
5567429526
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 november 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Håkansson Aldenmalm, Pia Elisabeth
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom organisationsut- veckling, hälso-, sjuk-, och friskvård, äga och förvalta fast egendom samt därmed förenlig verksamhet.
Address
Stuvhult Granbacken
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 197 | 1 435 | 1 422 | 1 030 | 841 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 375 | 634 | 723 | 422 | 189 |
| Depreciation & amort. | −44 | −44 | −44 | −43 | −36 |
| EBIT | 331 | 590 | 679 | 379 | 153 |
| Net financials | −6 | — | 3 | 41 | 47 |
| Profit before tax | 324 | 590 | 682 | 420 | 200 |
| Tax | −70 | −122 | −140 | −87 | −41 |
| Net profit | 254 | 468 | 542 | 333 | 159 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 558 | 4 902 | 5 358 | 5 654 | 4 687 |
| Equity | 3 390 | 3 458 | 3 750 | 3 833 | 3 742 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 168 | 1 443 | 1 607 | 1 821 | 945 |
| Total debt | 1 168 | 1 443 | 1 607 | 1 821 | 945 |
EBITDA margin
22.5%
This company
15.8%
Market median
+42% vs market
20202024
Equity ratio
79.8%
This company
38.2%
Market median
+109% vs market
20202024
Return on equity
4.2%
This company
18.4%
Market median
-77% vs market
20202024
Net profit margin
18.9%
This company
8.1%
Market median
+133% vs market
20202024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Pia Aldenmalm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl-Peter Bertil Kalle Wrane | Audit | 0 companies |
| Pia Elisabeth Håkansson Aldenmalm | Board of Directors | 0 companies |
| Carl-Magnus Lidén | Deputy Board Member | 0 companies |